Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
RESEARCH|Updated:2025-12-13
|
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
“Reporting on the latest research in the field of urology, the study presents a comprehensive assessment of the global burden of six common urologic diseases. The research, based on data from the Global Burden of Disease 2021, reveals that BPH and UTI are the leading causes of incidence and prevalence, while prostate cancer tops mortality and DALYs rates. The study also highlights the impact of risk factors such as high BMI and smoking on kidney, bladder, and prostate cancer deaths, underscoring the need for international collaboration to improve disease management.”
Military Medical ResearchVol. 12, Issue 7, Pages: 1007-1022(2025)
Affiliations:
1.Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
2.Evidence-Based Medicine Center, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Xiangyang 441000, Hubei, China
3.Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
4.Department of Urology, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan 430060, China
5.Department of Forensic Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
6.School of Clinical Medicine, Hubei University of Arts and Science, Xiangyang 441053, Hubei, China
7.Department of Urology, Institute of Urology, Peking University First Hospital, Peking University, The National Urological Cancer Center of China, Beijing 100034, China
Cite this article as: Zi H, Liu MY, Luo LS, Huang Q, Luo PC, Luan HH, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11(1):64.
DOI:
Cite this article as: Zi H, Liu MY, Luo LS, Huang Q, Luo PC, Luan HH, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11(1):64. DOI: 10.1186/s40779-024-00569-w.
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021